-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Development Pharmaceutical Co.
Prokalamide is a class 1.
During the development process, there were many surprises.
The discovery of the role of Prokalamide in the new crown involves a process of inductive reasoning and deductive reasoning
In February 2020, Kaifeng Pharmaceutical and Soochow University collected and analyzed the clinical data of 1,339 patients with new crowns, and carried out a series of cell in vitro tests to analyze the underlying mechanism
At the same time, there are many similar discoveries abroad
As a result, Pioneer Pharmaceuticals got in touch with Applied Biology in the United States, and cooperated in Brazil to launch a clinical study of procluamide for the treatment of COVID-19 initiated by the researcher
Inspired by the results of clinical trials for patients with mild and moderate new coronary disease, and with the strong support of the Brazilian health department, the clinical trial of procrulamide in the treatment of patients with severe new coronary disease has also obtained accelerated approval by the Brazilian Independent Review Board (IRB).